Alphabet as of Sept. 30, 2023
Portfolio Holdings for Alphabet
Alphabet holds 45 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Uipath Cl A (PATH) | 15.5 | $241M | 14M | 17.11 | |
| Crowdstrike Hldgs Cl A (CRWD) | 13.8 | $215M | 1.3M | 167.38 | |
| Verve Therapeutics (VERV) | 9.0 | $140M | 11M | 13.26 | |
| Gitlab Class A Com (GTLB) | 7.7 | $120M | 2.6M | 45.22 | |
| Prime Medicine (PRME) | 7.3 | $113M | 12M | 9.54 | |
| Eqrx | 6.8 | $106M | 48M | 2.22 | |
| Arm Holdings Sponsored Adr (ARM) | 6.7 | $105M | 2.0M | 53.52 | |
| Planet Labs Pbc Com Cl A (PL) | 5.3 | $83M | 32M | 2.60 | |
| Snowflake Cl A (SNOW) | 5.3 | $82M | 536k | 152.77 | |
| Oscar Health Cl A (OSCR) | 5.2 | $81M | 15M | 5.57 | |
| Freshworks Class A Com (FRSH) | 5.2 | $80M | 4.0M | 19.92 | |
| Dex (DXCM) | 3.9 | $61M | 655k | 93.30 | |
| Desktop Metal Com Cl A (DM) | 1.0 | $16M | 11M | 1.46 | |
| Relay Therapeutics (RLAY) | 0.8 | $13M | 1.6M | 8.41 | |
| Sana Biotechnology (SANA) | 0.7 | $11M | 2.8M | 3.87 | |
| Adagio Therapeutics (IVVD) | 0.6 | $9.7M | 5.7M | 1.70 | |
| Rapt Therapeutics (RAPT) | 0.6 | $9.0M | 540k | 16.62 | |
| Lyell Immunopharma (LYEL) | 0.6 | $8.6M | 5.9M | 1.47 | |
| Beam Therapeutics (BEAM) | 0.5 | $7.7M | 322k | 24.05 | |
| Illumina (ILMN) | 0.5 | $7.3M | 54k | 137.28 | |
| Monte Rosa Therapeutics (GLUE) | 0.5 | $7.0M | 1.5M | 4.79 | |
| Benson Hill Common Stock (BHIL) | 0.3 | $5.1M | 15M | 0.33 | |
| Vaccitech Ads (BRNS) | 0.3 | $4.7M | 1.5M | 3.09 | |
| Vera Therapeutics Cl A (VERA) | 0.3 | $4.1M | 302k | 13.71 | |
| Dianthus Therapeutics (DNTH) | 0.2 | $2.9M | 209k | 13.67 | |
| Neumora Therapeutics (NMRA) | 0.2 | $2.8M | 200k | 14.11 | |
| Tscan Therapeutics (TCRX) | 0.2 | $2.8M | 1.1M | 2.56 | |
| Foghorn Therapeutics (FHTX) | 0.2 | $2.5M | 501k | 5.00 | |
| Tenaya Therapeutics (TNYA) | 0.1 | $2.3M | 916k | 2.55 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $2.0M | 641k | 3.16 | |
| Kronos Bio (KRON) | 0.1 | $1.9M | 1.4M | 1.30 | |
| Hyperfine Com Cl A (HYPR) | 0.1 | $1.8M | 899k | 2.05 | |
| Autolus Therapeutics Spon Adr (AUTL) | 0.1 | $1.6M | 698k | 2.33 | |
| EXACT Sciences Corporation (EXAS) | 0.1 | $1.6M | 23k | 68.22 | |
| Science 37 Holdings | 0.1 | $1.3M | 3.2M | 0.40 | |
| Alector (ALEC) | 0.1 | $1.1M | 176k | 6.48 | |
| Spero Therapeutics (SPRO) | 0.1 | $1.1M | 890k | 1.21 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.1 | $973k | 449k | 2.17 | |
| Cortexyme (QNCX) | 0.0 | $212k | 189k | 1.12 | |
| Evelo Biosciences Com New (EVLO) | 0.0 | $208k | 53k | 3.92 | |
| Invitae (NVTAQ) | 0.0 | $144k | 236k | 0.61 | |
| Mondee Holdings Class A Com (MOND) | 0.0 | $66k | 18k | 3.57 | |
| Fulcrum Therapeutics (FULC) | 0.0 | $63k | 14k | 4.44 | |
| Repligen Corporation (RGEN) | 0.0 | $61k | 383.00 | 159.01 | |
| Cue Health (HLTH) | 0.0 | $12k | 27k | 0.44 |
